人工智能技术在PCI术后患者随访中的应用

Application of artificial intelligence technology in follow-up of patients after PCI

目的探讨基于人工智能技术的经皮冠状动脉介入治疗(percutaneous coronary intervention,PCI)术后患者随访方案的应用效果。方法通过文献回顾、专家函询构建PCI术后人工智能随访方案。选取2022年10月至2023年11月于南昌大学第二附属医院行PCI的冠心病患者82例,根据随机数字表法将其分为干预组和对照组,每组41例。对照组给予常规护理方案,干预组在对照组基础上增加基于人工智能的随访方案。比较两组患者干预6个月内的主要心血管不良事件(major adverse cardiovascular event,MACE)发生率、30d再入院率、服药依从性和满意度评分。结果干预组患者6个月内的MACE发生率及30d再入院率均显著低于对照组(P<0.05)。干预6个月后,两组患者的Morisky量表评分和满意度评分均显著高于本组干预前(P<0.05),干预组患者的Morisky量表评分和满意度评分均显著高于对照组(P<0.05)。结论基于人工智能技术的随访方案可降低PCI术后患者的MACE发生率及30d再入院率。

Objective To investigate the application of artificial intelligence-based follow-up plan for patients after percutaneous coronary intervention(PCI).Methods The follow-up plan of artificial intelligence after PCI was constructed through literature review and expert correspondence consultation.A total of 82 patients with coronary heart disease who underwent PCI in the Second Affiliated Hospital of Nanchang University from October 2022 to November 2023 were selected and divided into intervention group and control group according to random number table method,with 41 cases in each group.The control group was given routine nursing program,and the intervention group was added artificial intelligence-based follow-up program on the basis of control group.The incidence of major adverse cardiovascular event(MACE)within 6 months,30 days readmission rate,medication compliance and satisfaction score were compared between two groups.Results The incidence of MACE within 6 months and 30 days readmission rate in intervention group were significantly lower than those in control group(P<0.05).After 6 months of intervention,Morisky scale score and satisfaction score of patients in two groups were significantly higher than before intervention(P<0.05),and Morisky scale score and satisfaction score of patients in intervention group were significantly higher than those in control group(P<0.05).Conclusion Follow-up program based on artificial intelligence technology can reduce the incidence of MACE and 30 days readmission rate of patients after PCI.